Does synthetic pharmacotherapy still have a place in treating chronic spontaneous urticaria?

Rebecca M Thiede¹, Mohammad Fazel¹, Karen M MacDonald², Ivo Abraham^{2

3

4

5}

Affiliations

¹ Division of Dermatology, College of Medicine, University of Arizona, Tucson, AZ, USA.
² Matrix45, Tucson, AZ, USA.
³ Center for Health Outcomes and PharmacoEconomic Research, University of Arizona, Tucson, AZ, USA.
⁴ Department of Pharmacy Practice and Science, R. Ken Coit College of Pharmacy, University of Arizona, Tucson, AZ, USA.
⁵ Department of Family and Community Medicine, R. Ken Coit College of Pharmacy, University of Arizona, Tucson, AZ, USA.

Editorial

Rebecca M Thiede et al. Expert Opin Pharmacother. 2022 Oct.

. 2022 Oct;23(14):1563-1567.

doi: 10.1080/14656566.2022.2128671. Epub 2022 Sep 29.

Rebecca M Thiede¹, Mohammad Fazel¹, Karen M MacDonald², Ivo Abraham^{2

3

4

5}

¹ Division of Dermatology, College of Medicine, University of Arizona, Tucson, AZ, USA.
² Matrix45, Tucson, AZ, USA.
³ Center for Health Outcomes and PharmacoEconomic Research, University of Arizona, Tucson, AZ, USA.
⁴ Department of Pharmacy Practice and Science, R. Ken Coit College of Pharmacy, University of Arizona, Tucson, AZ, USA.
⁵ Department of Family and Community Medicine, R. Ken Coit College of Pharmacy, University of Arizona, Tucson, AZ, USA.

No abstract available

Keywords: H1 blockers; Urticaria; cyclosporin; omalizumab; spontaneous chronic urticaria; spontaneous idiopathic urticaria.

Publication types